Joanne M. Foody - Aug 8, 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Medical Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Aug 8, 2023
Transactions value $
$144,666
Form type
4
Date filed
8/9/2023, 04:30 PM
Previous filing
Apr 20, 2023
Next filing
Mar 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy Award $72.3K +44.7K $1.62 44.7K Aug 8, 2023 Stock Option (right to buy) 44.7K $1.62 Direct F1
transaction ESPR Stock Option (right to buy) Award $72.3K +44.7K $1.62 44.7K Aug 8, 2023 Stock Option (right to buy 44.7K $1.62 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on November 15, 2023, subject to continued service.
F2 Such award shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.